Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
E-pub ahead of print

ESPE and PES International Survey of Centers and Clinicians Delivering Specialist Care for Children and Adolescents with Gender Dysphoria

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Populations, decreasing fertility, and reproductive health

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Low-saturated-fat and low-cholesterol diet does not alter pubertal development and hormonal status in adolescents

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Variations in repeated serum concentrations of UV filters, phthalates, phenols and parabens during pregnancy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The AMH genotype (rs10407022 T>G) is associated with circulating AMH levels in boys, but not in girls

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Differential Impact of Genetic Loci on Age at Thelarche and Menarche in Healthy Girls

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Nicos Skordis
  • Gary Butler
  • Martine C de Vries
  • Katharina Main
  • Sabine E Hannema
Vis graf over relationer

BACKGROUND/AIMS: Increasing numbers of children and adolescents seek medical care because they experience incongruence between their physical sex and their gender identity.

METHODS: The ESPE working group on gender dysphoria (GD) undertook a survey to investigate the structure and the type of medical care in centers that offer specialist care for transgender adolescents.

RESULTS: The personnel of each center varied from country to country, and a nationally organized network or plan for managing GD did not exist in all centers. The majority of young people were transitioning from female to male, and the number of new referrals increased remarkably during the past 3 years. Almost all centers follow the guidelines issued by the Endocrine Society and World Professional Association for Transgender Health. GnRH analogues were used as the initial treatment in the majority of the centers. The age from which adolescents are treated with gender-affirming hormones varied between centers. Several legal restrictions that concern or influence the treatment of children and adolescents with GD were finally addressed.

CONCLUSION: This first international survey examining the variations in availability and provisions of services for children and adolescents with GD serves as a starting block for further dialogue and future studies.

OriginalsprogEngelsk
TidsskriftHormone research in paediatrics
Vol/bind90
Udgave nummer5
Sider (fra-til)1-6
Antal sider6
ISSN1663-2818
DOI
StatusE-pub ahead of print - 29 jan. 2019

ID: 56511514